Poonawalla, Well being Information, ET HealthWorld

Pune: The primary batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured on the Serum Institute of India‘s Pune facility, SII CEO Adar Poonawalla stated on Friday. “Excited to witness the primary batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune. The vaccine has nice potential to guard our future generations beneath the age of 18. Trials are ongoing. Nicely executed crew @seruminstindia,” Poonawalla stated in a tweet.

In March this yr, he had stated that the scientific trials of Covovax vaccine have begun in India and the corporate hopes to launch it by September this yr.

In August 2020, American vaccine firm Novavax Inc had introduced a licence settlement with SII for the event and commercialisation of NVX-CoV2373, its Covid-19 vaccine candidate, in low and middle-income international locations and India. In January this yr, the Serum Institute had rolled out Covishield vaccine within the nation. PTI



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *